| Stevens‐Johnson syndrome and toxic epidermal necrolysis‐like reactions to checkpoint inhibitors: a systematic review NJ Maloney, V Ravi, K Cheng, DQ Bach, S Worswick International journal of dermatology 59 (6), e183-e188, 2020 | 86 | 2020 |
| Off-label studies on apremilast in dermatology: a review NJ Maloney, J Zhao, K Tegtmeyer, EY Lee, K Cheng Journal of Dermatological Treatment 31 (2), 131-140, 2020 | 48 | 2020 |
| Neutrophilic dermatoses as adverse effects of checkpoint inhibitors: A review V Ravi, NJ Maloney, S Worswick Dermatologic therapy 32 (5), e13074, 2019 | 33 | 2019 |
| Off-label studies on tofacitinib in dermatology: a review K Tegtmeyer, J Zhao, NJ Maloney, G Atassi, M Beestrum, PA Lio Journal of Dermatological Treatment 32 (4), 399-409, 2021 | 31 | 2021 |
| Dupilumab in dermatology: potential for uses beyond atopic dermatitis NJ Maloney, K Tegtmeyer, J Zhao, S Worswick Journal of Drugs in Dermatology: JDD 18 (10), S1545961619P1053X …, 2019 | 27 | 2019 |
| Destabilization of MYC/MYCN by the mitochondrial inhibitors, metaiodobenzylguanidine, metformin and phenformin SS Wang, R Hsiao, MM Limpar, S Lomahan, TA Tran, NJ Maloney, ... International journal of molecular medicine 33 (1), 35-42, 2014 | 25 | 2014 |
| Alopecia areata as an immune‐related adverse event of immune checkpoint inhibitors: A review L Antoury, NJ Maloney, DQ Bach, C Goh, K Cheng Dermatologic Therapy 33 (6), e14171, 2020 | 22 | 2020 |
| Refractory pityriasis rubra pilaris treated with etanercept, adalimumab, or ustekinumab: a retrospective investigation NJ Maloney, LD Hisaw, S Worswick Dermatologic therapy 30 (6), e12559, 2017 | 22 | 2017 |
| Overlap between hemophagocytic lymphohistiocytosis and drug reaction and eosinophilia with systemic symptoms: a review JJ Yang, DK Lei, V Ravi, NJ Maloney, A Crew, S Worswick International Journal of Dermatology 60 (8), 925-932, 2021 | 21 | 2021 |
| Development of alopecia in patients treated with dupilumab NJ Maloney, S Worswick, K Cheng Dermatologic therapy 32 (3), e12869, 2019 | 16 | 2019 |
| Off-Label studies on anakinra in dermatology: a review K Tegtmeyer, G Atassi, J Zhao, NJ Maloney, PA Lio Journal of Dermatological Treatment 33 (1), 73-86, 2022 | 14 | 2022 |
| Type I pityriasis rubra pilaris treated with tumor necrosis factor inhibitors, ustekinumab, or secukinumab: A review NJ Maloney, LD Hisaw, S Worswick Journal of the American Academy of Dermatology 79 (3), 585-587, 2018 | 13 | 2018 |
| Characterizing Disease Features and Other Medical Diagnoses in Patients With Pityriasis Rubra Pilaris K Halper, B Wright, NJ Maloney, MM Kim, V Ravi, S Worswick, DK Lei JAMA dermatology 156 (12), 1373-1374, 2020 | 12 | 2020 |
| Machine learning for precision dermatology: Advances, opportunities, and outlook EY Lee, NJ Maloney, K Cheng, DQ Bach Journal of the American Academy of Dermatology, S0190-9622 (20) 32161-7, 2020 | 12 | 2020 |
| Sweet syndrome as an adverse reaction to tyrosine kinase inhibitors: A review JJ Yang, NJ Maloney, KA Nguyen, S Worswick, J Smogorzewski, ... Dermatologic Therapy 34 (1), e14461, 2021 | 11 | 2021 |
| Patient experiences with biologics and apremilast in pityriasis rubra pilaris: A patient survey NJ Maloney, MM Kim, KA Nguyen, LD Hisaw, S Worswick Dermatologic therapy 32 (5), e13060, 2019 | 8 | 2019 |
| Prurigo pigmentosa: A multi-institutional retrospective study A Shen, CE Cheng, R Malik, E Mark, N Vecerek, N Maloney, J Leavens, ... Journal of the American Academy of Dermatology, 2023 | 7 | 2023 |
| Off-label Studies on the Use of Ruxolitinib in Dermatology K Tegtmeyer, M Ravi, J Zhao, NJ Maloney, PA Lio Dermatitis 32 (3), 164-172, 2021 | 7 | 2021 |
| Patient and disease characteristics associated with psychiatric symptoms and impaired quality of life in pityriasis rubra pilaris A Ji‐Xu, DK Lei, S Worswick, NJ Maloney, MM Kim, L Cutler British Journal of Dermatology 187 (6), 1024-1026, 2022 | 6 | 2022 |
| Clinical course, diagnostic patterns, and treatment outcomes in patients with pityriasis rubra pilaris A Ji-Xu, DK Lei, NJ Maloney, S Worswick Journal of the American Academy of Dermatology 87 (6), 1450-1451, 2022 | 6 | 2022 |
